Coexistence of hereditary homocystinuria and Factor V Leiden - Effect on thrombosis

New England Journal of Medicine

Volumn 334, Issue 12, 1996, Pages 763-768

  Mandel, Hanna ^a   Brenner, Benjamin ^a   Berant, Moshe ^a   Rosenberg, Nurith ^b   Lanir, Naomi ^a   Jakobs, Cornelis ^c   Fowler, Brian ^d   Seligsohn, Uri ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; HOMOCYSTINE; PROTEIN C; WARFARIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HOMOCYSTINURIA; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS;

ADOLESCENT; BASE SEQUENCE; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; HOMOCYSTINURIA; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; PEDIGREE; POINT MUTATION; PROTEIN C; RISK FACTORS; THROMBOSIS;

EID: 0029933176     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199603213341204     Document Type: Article

References (42)

1. Holme E, Kjellman B, Ronge E. Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child 1989;64:1061-4
2. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration In: Scriver CR, Beaudet AL, Sly WS, Valle DL, eds. The metabolic and molecular bases of inherited disease. 7th ed. Vol 1 New York: McGraw-Hill, 1995: 1279-327.
3. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle DL, eds The metabolic and molecular bases of inherited disease, 7th ed. Vol 2. New York: McGraw-Hill, 1995:3111-28
4. Fenton WA, Rosenberg LE Inherited disorders of cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle DL, eds. The metabolic and molecular bases of inherited disease. 7th ed. Vol. 2. New York: McGraw-Hill, 1995:3129-49
5. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270.2693-8.
6. Selhub J, Jacques PF, Bostom AG, et al Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995,332:286-91.
7. Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 1985;37:1-31.
8. Dahlback B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism Blood 1995;85:607-14
9. Esmon CT The regulation of natural anticoagulant pathways. Science 1987; 235:1348-52.
10. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 1994,369: 647.
11. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994;343.1361-2.
12. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden Thrombophilia Study. Lancet 1993;342:1503-6.
13. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995;85:1504-8.
14. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994,84:1031-5
15. Koeleman BPC, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost 1995;74 580-3.
16. Vandenbroucke JP, Koster T, Briet E, Reitsma PH. Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 1994;344:1453-7.
17. Ubbink JB, Vermaak WJH, Bissbort S Rapid high-performance liquid chromatography assay for total homocysteine levels in human serum J Chromatogr 1991;565:441-6.
18. Sweetman L. Organic acid analysis. In Hommes FA, ed. Techniques in diagnostic human biochemical genetics: a laboratory manual New York. Wiley-Liss, 1991:143-76.
19. 4PteGlu reductase deficiency. J Clin Invest 1979;63:1019-25.
20. Uhlendorf BW, Mudd SH Cystathionine synthase in tissue culture derived from human skin: enzyme defect in homocystinuria. Science 1968; 160: 1007-9.
21. Boss GR. Cobalamin inactivation decreases purine and methionine synthesis in cultured lymphoblasts. J Clin Invest 1985;76:213-8.
22. Rosenblatt DS, Erbe RW. Methylenetetrahydrofolate reductase in cultured human cells. II. Genetic and biochemical studies of methylenetetrahydro-folate reductase deficiency. Pediatr Res 1977;11:1141-3.
23. 12) coenzyme synthesis and cobalamin-dependent enzymes in cultured skin fibroblasts Enzyme Protein 1994,47.180-1.
24. 12 responsive homocystinuria and megaloblastic anemia: heterogeneity in methylcobalamin deficiency. Am J Med Genet 1987;26:377-83.
25. 12 malabsorption N Engl J Med 1972;287:358.
26. Cutz E, Rhoads JM, Drumm B, Sherman PM, Durie PR, Forstner GG. Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med 1989;320:646-51
27. Gandrille S, Greengard JS, Alhenc-Gelas M, et al. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients Blood 1995;86: 219-24
28. Zoller B, Berntsdotter A, de Frutos PG, Dahlback B Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995;85:3518-23.
29. van Boven HH, Reitsma PH, Rosendaal FR, et al. Interaction of factor V Leiden with inherited antithrombin deficiency Thromb Haemost 1995;73: 1256 abstract.
30. Bauer KA. Management of patients with hereditary defects predisposing to thrombosis including pregnant women. Thromb Haemost 1995;74:94-100.
31. Lindblad B, Svensson PJ, Dahlback B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C. Lancet 1994; 343:917
32. Greengard JS, Eichinger S, Griffin JH, Bauer KA Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg→Gln mutation in the gene for factor V N Engl J Med 1994;331.1559-62
33. Burke G, Robinson K, Refsum H, Stuart B, Graham I. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med 1994;326 69-70.
34. Triplett DA. Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol 1989;20:52-67
35. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986;77. 1909-16.
36. Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 1990; 75:895-901.
37. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine J Clin Invest 1991;88.1906-14.
38. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease N Engl J Med 1991;324.1149-55
39. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, ed Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker, 1992:183-236.
40. Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993;71:337-59
41. Falcon CR, Cattaneo M, Panzeri D, Martielli I, Mannucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis Arterioscler Thromb 1994;14:1080-3.
42. Den Heijer M, Blom HJ, Gerrits WBJ, et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 1995;345:882-5.